mitomycin has been researched along with trichostatin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarawal, A; Kharya, MD; Parmar, P; Rajak, H; Sharma, PC; Thakur, BS; Veerasamy, R | 1 |
| Conway, RM; Cunneen, TS; Madigan, MC | 1 |
2 other study(ies) available for mitomycin and trichostatin a
| Article | Year |
|---|---|
2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Proliferation; Drug Design; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Hydroxamic Acids; Mice; Neoplasms; Oxadiazoles; Structure-Activity Relationship; Surface Properties; Thiadiazoles; Zinc | 2011 |
In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells.
Topics: Apoptosis; Butyrates; Cell Cycle; Cell Proliferation; Cell Survival; Conjunctival Neoplasms; Connective Tissue Cells; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Flow Cytometry; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Melanoma; Mitomycin; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2009 |